PINK vs. CNCR
PINK (Simplify Health Care ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. PINK is actively managed, while CNCR is passively managed. PINK charges 0.50%/yr vs 0.79%/yr for CNCR.
Performance
PINK vs. CNCR - Performance Comparison
Loading charts...
Returns By Period
PINK
- 1D
- 1.24%
- 1M
- 7.28%
- YTD
- 2.39%
- 6M
- 2.11%
- 1Y
- 31.27%
- 3Y*
- 14.42%
- 5Y*
- —
- 10Y*
- —
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PINK vs. CNCR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
PINK Simplify Health Care ETF | 3.10% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
PINK vs. CNCR - Sectors Allocation Comparison
Sectors
PINK
CNCR
Healthcare
Industrials
-
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PINK
CNCR
Industrials
PINK
CNCR
-
Financial Services
PINK
CNCR
Basic Materials
PINK
-
CNCR
-
Communication Services
PINK
-
CNCR
-
Consumer Cyclical
PINK
-
CNCR
-
Consumer Defensive
PINK
-
CNCR
-
Energy
PINK
-
CNCR
-
Real Estate
PINK
-
CNCR
-
Technology
PINK
-
CNCR
-
Utilities
PINK
-
CNCR
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PINK vs. CNCR — Risk / Return Rank
PINK
CNCR
PINK vs. CNCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Simplify Health Care ETF (PINK) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PINK | CNCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.29 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.87 | — | — |
| Martin ratioReturn relative to average drawdown | 5.62 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PINK | CNCR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.73 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.56 | — | — |
Drawdowns
PINK vs. CNCR - Drawdown Comparison
The maximum PINK drawdown since its inception was -18.77%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PINK and CNCR.
Loading charts...
Drawdown Indicators
| PINK | CNCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.77% | 0.00% | -18.77% |
Max Drawdown (1Y)Largest decline over 1 year | -16.81% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -18.77% | — | — |
Current DrawdownCurrent decline from peak | -2.84% | 0.00% | -2.84% |
Average DrawdownAverage peak-to-trough decline | -6.75% | 0.00% | -6.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.57% | — | — |
Volatility
PINK vs. CNCR - Volatility Comparison
Loading charts...
Volatility by Period
| PINK | CNCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.36% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 13.44% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.17% | 0.00% | +18.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.57% | 0.00% | +17.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.57% | 0.00% | +17.57% |
PINK vs. CNCR - Expense Ratio Comparison
PINK has a 0.50% expense ratio, which is lower than CNCR's 0.79% expense ratio.
Dividends
PINK vs. CNCR - Dividend Comparison
PINK's dividend yield for the trailing twelve months is around 0.67%, while CNCR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PINK Simplify Health Care ETF | 0.67% | 0.68% | 0.32% | 0.94% | 0.42% | 0.04% |
Frequently Asked Questions
On fees, PINK is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PINK is cheaper with a 0.50% expense ratio, compared with 0.79% for CNCR.
PINK has the higher dividend yield at 0.67%, compared with 0.00% for CNCR.
They also come from different issuers: Simplify and Exchange Traded Concepts. Their fees differ too: 0.50% for PINK and 0.79% for CNCR.
Find the right allocation for PINK and CNCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer